Because life expectancy for individuals with Down syndrome has increased dramatically, investigators assessed the risk of age-related cardiovascular diseases in this population. As reported in the Journal of Internal Medicine, ...
5 minutes ago
0
0
A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.
11 hours ago
0
19
A test commonly used to confirm a condition linked to high blood pressure is often inaccurate, causing doctors to skip treatment that might improve patients' heart health, a new study says.
13 hours ago
0
11
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection—even when standard medical tests return normal results—potentially placing ...
14 hours ago
0
0
Screening for common genetic variants in addition to rare genetic variants can help improve patient risk stratification for heart failure, according to a recent study published in Nature Genetics led by investigators at Northwestern ...
14 hours ago
0
0
